Brazil's Booming Black Market for GLP-1 Weight-Loss Drugs Raises Safety Alarms
核心洞察
Brazilian authorities seized more than 76,000 pens, vials and other products containing semaglutide and tirzepatide at the Paraguay border in the first half of 2026, nearly three times the total for all of 2025.
The illicit trade, valued at an estimated $485 million in black-market revenue, is increasingly attracting organized crime groups drawn by the drugs' small size and high value.
Endocrinologist Dr. Alexandre Hohl warns that improperly stored or counterfeit peptide drugs can lose effectiveness or cause serious harm, including a patient who developed lactic acidosis (搜索) and required intensive care.
More than 76,000 pens, vials and other products containing GLP-1 medications such as semaglutide and tirzepatide were seized along the Brazilian-Paraguay border in the first half of 2026 — nearly three times the number confiscated during all of last year, according to data from Brazil's Federal Revenue Service. The surge has transformed weight-loss drugs into one of the most valuable categories of contraband in the region, as smugglers capitalize on soaring demand in Brazil and significantly lower prices across the border.
The drugs now rank second in value among goods seized by Federal Revenue officials in the region encompassing the southern states of Paraná and Santa Catarina, behind only cell phones, according to federal tax auditor Flávio Bernardino de Carvalho. "They come on public buses, in cars, in trucks, with tourists. Every possible way," Carvalho told CNN Brasil. "There's organized crime and there are individuals. It's very dispersed."
A Lucrative Cross-Border Trade
The economics driving the illicit market are stark. Mounjaro, the only authorized tirzepatide medication in Brazil, is manufactured by American pharmaceutical Eli Lilly and Company and can cost upwards of 1,400 reais (about $280) for a weekly dose. In Paraguay, an ampoule of locally manufactured tirzepatide sells for about 340 reais (about $68), according to Brazil's Federal Revenue Service. Last year, Brazilian bank Itaú BBA estimated the black market revenue of the tirzepatide trade at $485 million.
Public security expert José Ricardo Bandeira told CNN Brasil that these economics are changing the incentives for criminal groups that have historically profited from cigarette smuggling. "Organized crime is migrating. There's a logic to it," Bandeira said. "Cigarette smuggling requires enormous logistics. You need trucks to transport the cigarettes and a series of measures to get the contraband into Brazil."
The small size of weight-loss drugs makes logistics easier and significantly more cost effective. While a pack of cigarettes costs about 850 times less than a vial of tirzepatide, according to Federal Revenue data, it is bulkier to transport. "Because of their small size and high value, the pens are much more attractive," Bandeira said. "With a few boxes of pens, you can make the same profit you would smuggling a truckload of cigarettes."
Organized Crime and Violence
The trade is increasingly attracting established criminal organizations. Carlos Dure, Commissioner of the Tripartite Command, a police alliance between the authorities of Argentina, Brazil and Paraguay, told the Organized Crime and Corruption Reporting Project (OCCRP) that his forces see an average of almost one large-scale tirzepatide robbery per week, in addition to minor robberies and thefts in pharmacies.
"It is generating a huge, huge amount of illicit funds for criminal organizations, in addition to what they earn through what we typically refer to as drug or arms trafficking, or whatever else," said Dure. "This is bringing them a great deal of money."
The National Police of Paraguay suspect the participation of members of the First Capital Command (PCC) faction, Brazil's most powerful organized crime group, Dure added. "The same crews executing bank robberies and financial institution heists are also carrying out these pharmaceutical hijackings, because they utilize the exact same violence and tactical elements, such as heavy-caliber weaponry," Dure said.
Paraguayan prosecutor Italo Rienzo told reporters that he suspected the involvement of Brazilian criminal group Comando Vermelho in the trade, describing pharmaceuticals as "the new black gold" for criminal groups on the border. According to Paraguayan police records, armed gangs staged three major robberies targeting trucks and pharmacies for large quantities of tirzepatide in Paraguay this year. On the morning of March 23, assailants with machine guns and rifles took 1,100 vials from a distributor in Ciudad del Este, murdering one of the company's security guards.
However, not all law enforcement officials agree on the extent of organized crime involvement. Emerson Rodrigues, a high-ranking police officer in Foz do Iguaçu, told reporters that the smuggling networks are pre-existing and do not rely on established organized crime groups. "We have identified a decentralized logistics system that has already been in place for decades on the border through cigarette smuggling, without major criminal actors," he said.
Clinical Risks of Illicit Medications
Beyond the illegality of the trade, health workers warn of serious adverse consequences for consumers who purchase these drugs through informal sellers. Dr. Alexandre Hohl, a professor of endocrinology and metabolism at the Federal University of Santa Catarina and a director of the Brazilian Association for the Study of Obesity (搜索) and Metabolic Syndrome, has long advocated against the illicit use of medications.
"Whenever you look for medicine outside a pharmacy, you're taking risks," Hohl said. He explained that legitimate drugs pass through a carefully controlled supply chain before reaching patients. Drugs such as semaglutide and tirzepatide are peptides, molecules that require controlled conditions during transportation and storage — conditions unlikely to be met when illicit products are carried across the border concealed in vehicles, shoes, or against a person's body.
Hohl said peptide drugs can lose stability when exposed to temperatures above 30 degrees Celsius (86 degrees Fahrenheit) or below 0 degrees Celsius (32 degrees Fahrenheit). The likely outcome of improper storage is reduced effectiveness, meaning consumers may pay less for a medication that ultimately does not work as intended. But the consequences can potentially be far more serious.
Hohl described a patient who ended up in intensive care after using a product sold as tirzepatide from Paraguay. The woman, who was at a normal weight and had purchased the drug without a prescription or medical indication, developed lactic acidosis (搜索), a potentially serious buildup of acid in the blood. In another case, a patient switched from an authorized version of tirzepatide to a product purchased in Paraguay and soon developed nausea, vomiting and diarrhea, ultimately ending up in emergency care.
"Persistent nausea, abdominal pain, headache, skin reactions are some of the symptoms that I've seen," Hohl said. "Immune system reactions, effects that we didn't see when the original drug was studied, more severe side effects… those are things that could potentially happen."
Counterfeits and Unapproved Drugs
Counterfeit drugs are also present in the illegal market. In July this year, Paraguayan police seized 4,000 vials supposedly made by a Paraguayan company, Indufar, but found only saline inside the bottles. Dure said his forces are also seeing Chinese imports of the drug that are similar or identical to what Paraguay produces.
The illicit market may already be moving beyond the current generation of weight-loss drugs. Hohl said one of his patients reported using a product sold as retatrutide, an experimental weight-loss drug being developed by Eli Lilly. Retatrutide has not been approved by the US Food and Drug Administration — or by any other regulatory agency in the world — and is legally available only to participants in Lilly-sponsored clinical trials. The company, which has reported positive results from several Phase 3 trials this year, says it plans to submit the drug to the FDA for approval in the first quarter of 2027. Yet products marketed as retatrutide are already being sold in Paraguay.
Regulatory Response
As demand increases, Brazilian authorities are stepping up cooperation with Paraguay to tackle the growing illicit market. Brazil's health regulator Anvisa signed an agreement with Paraguay's National Directorate of Health Surveillance, or Dinavisa, to strengthen oversight along the border between the two countries.
Paraguay's National Directorate of Health Surveillance told reporters that it has implemented a traceability system to more effectively track tirzepatide. "Each package is required to have a unique code that allows for identifying the specific unit and linking it to the corresponding manufacturing or import batch. Unit identity constitutes a firm first regulatory step to strengthen safety and counterfeit detection capacity," the directorate said.
Online orders associated with GLP-1 medications increased 149.3% in Brazil during the first half of 2026, according to a survey by Serasa Experian, a private Brazilian data and credit services company. Requests climbed from 547,249 in the previous six-month period to more than 1.36 million between January and June, representing more than 2.3 billion reais (about $460 million) in purchases.
For Brazilian health officials and doctors, the most troubling aspect of the boom may be how quickly the illicit market is moving. "Access is very easy," Hohl said. "Today, you can buy it online. You can buy it anywhere. But people need to be careful about what they put in their bodies."
